Chiavegatto S, Nasello A G, Bernardi M M
Department of Pharmacology, Biomedical Sciences Institute, University of Sao Paulo, SP, Brazil.
Life Sci. 1998;62(20):1875-88. doi: 10.1016/s0024-3205(98)00154-4.
The time- and dose-related effects of exogenous histamine on spontaneous motor activity and receptors involved were evaluated in male rats. Intracerebroventricular administration of histamine (5.4 and 54.3 nmol) produced a biphasic effect with initial transitory hypoactivity and later hyperactivity expressed by locomotion frequency in an open-field. The rearing frequencies were only reduced by all doses of histamine used. The histamine-induced hypoactivity was inhibited by the H3-antagonist thioperamide and was also induced by the H3-agonist N-alpha-methylhistamine. The histamine-induced hyperactivity phase was blocked by the H1-antagonist mepyramine. The H2-antagonist ranitidine increased locomotion and rearing frequencies. The participation of other neurotransmitters in the persistent hypokinetic effect induced by 135.8 nmol of histamine was determined by HPLC in the striatum and hypothalamus as counter-proof. A decreased DOPAC/DA ratio was observed only in the striatum. In the hypothalamus, low levels of 5HT were detected, probably not correlated with motor activity. In conclusion, the present results suggest that the exogenous histamine-induced hypoactivity response is probably due to activation of H3-receptors as heteroreceptors reducing the activity of the striatal dopaminergic system. This effect can partially overlap with the expression of the hyperactivity induced by H1-receptor activation. The participation of H2-receptors requires further investigation.
在雄性大鼠中评估了外源性组胺对自发运动活动及相关受体的时间和剂量效应。脑室内注射组胺(5.4和54.3纳摩尔)产生了双相效应,最初是短暂的活动减少,随后是在旷场中通过运动频率表现出的活动亢进。所有使用剂量的组胺仅降低了竖毛频率。组胺诱导的活动减少被H3拮抗剂硫代哌啶抑制,并且也由H3激动剂N-α-甲基组胺诱导。组胺诱导的活动亢进阶段被H1拮抗剂美吡拉敏阻断。H2拮抗剂雷尼替丁增加了运动和竖毛频率。通过高效液相色谱法测定纹状体和下丘脑中其他神经递质对135.8纳摩尔组胺诱导的持续运动减少效应的参与情况作为反证。仅在纹状体中观察到DOPAC/DA比值降低。在下丘脑中,检测到低水平的5-羟色胺,可能与运动活动无关。总之,目前的结果表明,外源性组胺诱导的活动减少反应可能是由于H3受体作为异受体激活,降低了纹状体多巴胺能系统的活性。这种效应可能与H1受体激活诱导的活动亢进的表达部分重叠。H2受体的参与需要进一步研究。